Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK TRANSACTIONS (Details Narrative)

COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended					3 Months Ended		6 Months Ended
COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)	Apr. 09, 2021	Jan. 31, 2022	Sep. 30, 2021	Aug. 31, 2021	Jan. 31, 2021	Sep. 30, 2020	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2022	Oct. 31, 2021	Oct. 31, 2020	Aug. 09, 2021
Class of Stock [Line Items]
Exercise shares	2,500,000
Offering cost												$ 15,000,000
Stock consideration received				$ 10,720,000
Shares Issued				2,522,387
Common Warrants [Member]
Class of Stock [Line Items]
Warrant Exercised				2,522,387
Third S 3 Shelf Offering [Member]
Class of Stock [Line Items]
Stock issued new, shares	19,100,000
Proceeds from sale of equity	$ 87,400,000
Non Employee Board Member 1 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares											1,334
Non Employee Board Member 2 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares											1,334
Non Employee Board Member 3 [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock issued for compensation, shares											1,334
Three Nonemployee Board Members [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 971	$ 0	$ 4,342
Number of nonvested shares							0		0
A Consultant [Member] \| Medical And Scientific Advisory Board [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 1,417	$ 0	$ 3,542
Number of nonvested shares							0	0	0	0
Number of shares issued for compensation						333
Officers [Member] \| Compensation Agrmt 2021 [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 11,055	$ 0	$ 22,110
Number of nonvested shares							0	733	0	733
Number of shares issued for compensation					4,400
Officers [Member] \| Compensation Agrmt 2022 [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 3,917	$ 0	$ 6,667	$ 0
Number of nonvested shares							267	0	267	0
Number of shares issued for compensation		4,400
Three Nonemployee Members 1 [Member] \| Director Letter Agreement [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 5,851	$ 0	$ 10,736
Number of nonvested shares							0	0	0	0
Number of shares issued for compensation										1,336
Two Consultants [Member] \| Consulting Agreements [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 2,442	$ 0	$ 4,062
Number of nonvested shares							0	167	0	167
Number of shares issued for compensation										334
A Consultant 1 [Member] \| Medical And Scientific Advisory Board [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 88	$ 0	$ 88
Number of nonvested shares							0	0	0	0
Number of shares issued for compensation			334
Three Nonemployee 2 Members [Member] \| Director Letter Agreement [Member]
Class of Stock [Line Items]
Number of nonvested shares							0	0	0	0
Three Nonemployee 2 Members [Member] \| Director Letter Agreement [Member] \| Common Stock [Member]
Class of Stock [Line Items]
Stock based compensation expense							$ 0	$ 0	$ 2,278	$ 2,278
Number of shares issued for compensation									1,002